company background image
8307

Medicskin HoldingsSEHK:8307 Stock Report

Market Cap

HK$111.1m

7D

0%

1Y

60.0%

Updated

22 Oct, 2021

Data

Company Financials
8307 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health4/6
Dividends0/6

8307 Overview

Medicskin Holdings Limited, an investment holding company, provides medical skin care services primarily in Hong Kong.

Price History & Performance

Summary of all time highs, changes and price drops for Medicskin Holdings
Historical stock prices
Current Share PriceHK$0.28
52 Week HighHK$0.10
52 Week LowHK$0.38
Beta0.70
1 Month Change32.07%
3 Month Change-3.45%
1 Year Change60.00%
3 Year Change-1.75%
5 Year Change-73.08%
Change since IPO-91.03%

Recent News & Updates

Sep 15
Shareholders Will Probably Hold Off On Increasing Medicskin Holdings Limited's (HKG:8307) CEO Compensation For The Time Being

Shareholders Will Probably Hold Off On Increasing Medicskin Holdings Limited's (HKG:8307) CEO Compensation For The Time Being

In the past three years, shareholders of Medicskin Holdings Limited ( HKG:8307 ) have seen a loss on their investment...

Shareholder Returns

8307HK HealthcareHK Market
7D0%-0.3%1.8%
1Y60.0%-44.4%5.7%

Return vs Industry: 8307 exceeded the Hong Kong Healthcare industry which returned -44.4% over the past year.

Return vs Market: 8307 exceeded the Hong Kong Market which returned 5.7% over the past year.

Price Volatility

Is 8307's price volatile compared to industry and market?
8307 volatility
8307 Beta0.70
Industry Beta0.88
Market Beta1

Stable Share Price: 8307 is more volatile than 90% of Hong Kong stocks over the past 3 months, typically moving +/- 18% a week.

Volatility Over Time: 8307's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.

About the Company

FoundedEmployeesCEOWebsite
200039Kwok Leung Konghttps://www.medicskin.com

Medicskin Holdings Limited, an investment holding company, provides medical skin care services primarily in Hong Kong. The company operates Medicskin centers, which provides various medical skin care services for the treatment of skin diseases and problems, such as acne, pigmentation, rosacea, dermatitis, eczema, and warts, as well as improvement of appearance through alia, skin rejuvenation, facial sculpturing, and body contouring treatments; and treatment of acne scars and enlarged pores, removal of undesirable naevi, and hair removal, as well as lasers and light sources treatment, ultrasound treatment, and radio-frequency treatment. It is also involved in the sale of skincare products; provision of skin care and health management services; and property holding activities.

Medicskin Holdings Fundamentals Summary

How do Medicskin Holdings's earnings and revenue compare to its market cap?
8307 fundamental statistics
Market CapHK$111.09m
Earnings (TTM)HK$1.59m
Revenue (TTM)HK$44.99m

70.0x

P/E Ratio

2.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
8307 income statement (TTM)
RevenueHK$44.99m
Cost of RevenueHK$28.04m
Gross ProfitHK$16.95m
ExpensesHK$15.36m
EarningsHK$1.59m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

Nov 11, 2021

Earnings per share (EPS)0.004
Gross Margin37.68%
Net Profit Margin3.53%
Debt/Equity Ratio32.1%

How did 8307 perform over the long term?

See historical performance and comparison

Valuation

Is Medicskin Holdings undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 8307 (HK$0.28) is trading below our estimate of fair value (HK$0.63)

Significantly Below Fair Value: 8307 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 8307 is poor value based on its PE Ratio (70x) compared to the Hong Kong Healthcare industry average (16.5x).

PE vs Market: 8307 is poor value based on its PE Ratio (70x) compared to the Hong Kong market (9.7x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 8307's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 8307 is overvalued based on its PB Ratio (4.7x) compared to the HK Healthcare industry average (1.7x).


Future Growth

How is Medicskin Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

29.3%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medicskin Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Medicskin Holdings performed over the past 5 years?

-36.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 8307 has a large one-off gain of HK$1.8M impacting its June 30 2021 financial results.

Growing Profit Margin: 8307 became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: 8307's earnings have declined by 36.7% per year over the past 5 years.

Accelerating Growth: 8307 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 8307 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (29.5%).


Return on Equity

High ROE: 8307's Return on Equity (9.5%) is considered low.


Financial Health

How is Medicskin Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 8307's short term assets (HK$45.9M) exceed its short term liabilities (HK$38.2M).

Long Term Liabilities: 8307's short term assets (HK$45.9M) exceed its long term liabilities (HK$661.0K).


Debt to Equity History and Analysis

Debt Level: 8307's debt to equity ratio (32.1%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if 8307's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 8307's debt is well covered by operating cash flow (142.5%).

Interest Coverage: Insufficient data to determine if 8307's interest payments on its debt are well covered by EBIT.


Balance Sheet


Dividend

What is Medicskin Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 8307's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 8307's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 8307's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 8307's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: 8307 is not paying a notable dividend for the Hong Kong market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 8307's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

7.6yrs

Average management tenure


CEO

Kwok Leung Kong (67 yo)

3.58yrs

Tenure

HK$4,737,000

Compensation

Dr. Kwok Leung Kong serves as Chief Executive officer of Medicskin Holdings Ltd (“Company”) since March 01, 2018 and serves as its Founder and Chairman of the Board. Dr. Kong graduated from the Faculty of...


CEO Compensation Analysis

Compensation vs Market: Kwok Leung's total compensation ($USD609.31K) is above average for companies of similar size in the Hong Kong market ($USD228.05K).

Compensation vs Earnings: Kwok Leung's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: 8307's management team is seasoned and experienced (7.6 years average tenure).


Board Members

Experienced Board: 8307's board of directors are considered experienced (6.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Medicskin Holdings Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Medicskin Holdings Limited
  • Ticker: 8307
  • Exchange: SEHK
  • Founded: 2000
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: HK$111.086m
  • Shares outstanding: 396.74m
  • Website: https://www.medicskin.com

Number of Employees


Location

  • Medicskin Holdings Limited
  • Champion Building
  • 16th Floor
  • Central
  • Hong Kong

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/22 15:49
End of Day Share Price2021/10/22 00:00
Earnings2021/06/30
Annual Earnings2021/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.